Matches in Wikidata for { <http://www.wikidata.org/entity/Q89176619> ?p ?o ?g. }
Showing items 1 to 53 of
53
with 100 items per page.
- Q89176619 description "artículu científicu espublizáu en setiembre de 2018" @default.
- Q89176619 description "scientific article published on 01 September 2018" @default.
- Q89176619 description "wetenschappelijk artikel" @default.
- Q89176619 description "наукова стаття, опублікована у вересні 2018" @default.
- Q89176619 name "Zoledronic acid is superior to tenofovir disoproxil fumarate-switching for low bone mineral density in adults with HIV" @default.
- Q89176619 name "Zoledronic acid is superior to tenofovir disoproxil fumarate-switching for low bone mineral density in adults with HIV" @default.
- Q89176619 type Item @default.
- Q89176619 label "Zoledronic acid is superior to tenofovir disoproxil fumarate-switching for low bone mineral density in adults with HIV" @default.
- Q89176619 label "Zoledronic acid is superior to tenofovir disoproxil fumarate-switching for low bone mineral density in adults with HIV" @default.
- Q89176619 prefLabel "Zoledronic acid is superior to tenofovir disoproxil fumarate-switching for low bone mineral density in adults with HIV" @default.
- Q89176619 prefLabel "Zoledronic acid is superior to tenofovir disoproxil fumarate-switching for low bone mineral density in adults with HIV" @default.
- Q89176619 P1433 Q89176619-595006AF-5D17-45A7-AE9A-EFB4E2A353ED @default.
- Q89176619 P1476 Q89176619-E8341F5B-0B87-4E18-B216-421BE47CA6D9 @default.
- Q89176619 P2093 Q89176619-3302DD50-3C53-4FF5-8B16-B806AD275E86 @default.
- Q89176619 P2093 Q89176619-5C5754B6-C8E1-440D-8DBC-F4AE3B6F6883 @default.
- Q89176619 P2093 Q89176619-8627B1B3-CDB4-48CF-9DE8-ECA8DCFBA9DA @default.
- Q89176619 P2093 Q89176619-9017F37B-574B-4551-BC0C-A6D9BB9B0D2E @default.
- Q89176619 P2093 Q89176619-A5569906-7BB2-4B1D-A419-22FBBE7C6281 @default.
- Q89176619 P2093 Q89176619-AC623269-81F7-4605-B439-AD2EED3AE14F @default.
- Q89176619 P2093 Q89176619-CA4035D1-5281-4002-835B-7B9FA2CDE8EA @default.
- Q89176619 P2093 Q89176619-F5542C26-6E8D-45AE-85DB-71EE514A4A6F @default.
- Q89176619 P304 Q89176619-6A9A161E-2CAC-4514-A185-6ED6232DE5E5 @default.
- Q89176619 P31 Q89176619-E6E046F3-E9A2-4E7A-A697-9C4CD7F05968 @default.
- Q89176619 P356 Q89176619-00CDF56A-20CF-4D96-82B2-F27896E38D79 @default.
- Q89176619 P433 Q89176619-4E76044B-CD86-4651-A606-C246C9A667A1 @default.
- Q89176619 P478 Q89176619-FE1AA8C4-35C4-42EC-9845-8DF6A219E0D6 @default.
- Q89176619 P50 Q89176619-8A1AF7F9-270E-4CB0-86FB-C4DA417730B7 @default.
- Q89176619 P577 Q89176619-EF0FF201-BB34-4C7F-8366-7B846BC46AED @default.
- Q89176619 P698 Q89176619-195CE400-18BE-4DB2-A874-D24B6F1F4029 @default.
- Q89176619 P921 Q89176619-D8DB698E-A6E8-4094-8729-EE7CD0DE79E4 @default.
- Q89176619 P921 Q89176619-E8653547-2B8E-4DCC-83E1-F5917D5C37A1 @default.
- Q89176619 P356 QAD.0000000000001911 @default.
- Q89176619 P698 29927785 @default.
- Q89176619 P1433 Q4651863 @default.
- Q89176619 P1476 "Zoledronic acid is superior to tenofovir disoproxil fumarate-switching for low bone mineral density in adults with HIV" @default.
- Q89176619 P2093 "Andrew Carr" @default.
- Q89176619 P2093 "Esteban Martinez" @default.
- Q89176619 P2093 "Jennifer F Hoy" @default.
- Q89176619 P2093 "Jhon Rojas" @default.
- Q89176619 P2093 "Nicholas Pocock" @default.
- Q89176619 P2093 "Peter R Ebeling" @default.
- Q89176619 P2093 "Robyn Richardson" @default.
- Q89176619 P2093 "ZEST Study Investigators" @default.
- Q89176619 P304 "1967-1975" @default.
- Q89176619 P31 Q13442814 @default.
- Q89176619 P356 "10.1097/QAD.0000000000001911" @default.
- Q89176619 P433 "14" @default.
- Q89176619 P478 "32" @default.
- Q89176619 P50 Q42509307 @default.
- Q89176619 P577 "2018-09-01T00:00:00Z" @default.
- Q89176619 P698 "29927785" @default.
- Q89176619 P921 Q155954 @default.
- Q89176619 P921 Q218507 @default.